Apr 20, 2018
Notice of Completion of Disposal of Treasury Shares as Restricted Stock Compensation Plan
| Name of listed company: | Chugai Pharmaceutical Co., Ltd. |
| Code number: | 4519 (1st Section of Tokyo Stock Exchange) |
| Head office: | 1-1, Nihonbashi-Muromachi 2-Chome, Chuo-ku, Tokyo |
| President & CEO: | Tatsuro Kosaka |
| Inquiries to: | Masahiko Uchida, General Manager, |
| Corporate Communications Dept. | |
| Tel:+81-(0)3-3273-0881 |
Chugai Pharmaceutical Co., Ltd. (the “Company”) hereby announces that, disposal of treasury shares was completed on April 20, 2018, as we announced in the press release “Notice of Disposal of Treasury Shares as Restricted Stock Compensation Plan” on March 23, 2018. The result of treasury shares are as follows.
1.Overview of Disposal
| (1) | Disposal date | April 20, 2018 | ||
| (2) | Class and number of disposed shares | 60,300 shares of Common stock of the Company | ||
| (3) | Disposal price | ¥5,400 per share | ||
| (4) | Total value of disposed shares | ¥325,620,000 | ||
| (5) | Allottees and number thereof; number of disposed shares |
Directors | 3 | 32,700 shares |
| Vice presidents | 18 | 15,300 shares | ||
| Employees | 101 | 12,300 shares | ||
End of document
Contact:
- For Media
- Chugai Pharmaceutical Co., Ltd.
- Media Relations Group, Corporate Communications Dept.,
- Tomoko Shimizu
- Tel: +81-3-3273-0881
- E-mail: pr@chugai-pharm.co.jp
- For Investors
- Chugai Pharmaceutical Co., Ltd.
- Investor Relations Group, Corporate Communications Dept.,
- Toshiya Sasai
- Tel: +81-3-3273-0554
- E-mail: ir@chugai-pharm.co.jp
